Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

8/27/24 Aspirin BID + Anticoagulant Warning: Applied in PROD Today
August 27, 2024

Med Safety has recently received reports of Ortho Surgery patients receiving aspirin BID along with other anticoagulation (ex. Lovenox for VTE Prophylaxis) resulting in bleeding events/blood transfusion.

 

In order to address this, we have increased the Drug-Drug Interaction severity between aspirin BID and enoxaparin/dabigatran/apixaban/rivaroxaban/warfarin.  It will present as a standard Drug-Drug interaction alert as seen below:

Example

 

Please note that this trigger should be specific to only instances where aspirin is ordered BID.  If you encounter any examples where this alert is presented inappropriately, please let us know so that we can troubleshoot.  Thank you.

Aaron B. Atkins, Pharm.D., BCPS
Clinical Pharmacist, Informatics Lead
Huntsville Hospital
(256)265-3276

 

 

 

 






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved